We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Top Buys

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$6.56M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.36M
3
ILMN icon
Illumina
ILMN
+$3.21M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3M
5
RBA icon
RB Global
RBA
+$2.93M

Top Sells

Rank Stock Value
1
PFFD icon
Global X US Preferred ETF
PFFD
+$5.94M
2
VST icon
Vistra
VST
+$5.92M
3
GDDY icon
GoDaddy
GDDY
+$5M
4
SMCI icon
Super Micro Computer
SMCI
+$4.37M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VHT icon
3226
Vanguard Health Care ETF
VHT
$18.9B
– –
-20
Closed -$5.5K
VIGL
3227
DELISTED
Vigil Neuroscience
VIGL
– –
-1,327
Closed -$4.53K
VKTX icon
3228
Viking Therapeutics
VKTX
$4B
– –
-10,278
Closed -$843K
VOR icon
3229
Vor Biopharma
VOR
$1.23B
– –
-156
Closed -$7.37K
VUZI icon
3230
Vuzix
VUZI
$220M
– –
-4,601
Closed -$5.57K
WKHS icon
3231
Workhorse Group
WKHS
$32.7M
– –
-4
Closed -$2.81K
WW
3232
DELISTED
WW International
WW
– –
-5,378
Closed -$9.95K
XAIR icon
3233
Beyond Air
XAIR
$5.1M
– –
-5
Closed -$3.68K
ZVIA icon
3234
Zevia
ZVIA
$105M
– –
-2,059
Closed -$2.41K
TBRG
3235
DELISTED
TruBridge
TBRG
– –
-1,409
Closed -$13K
LOGC
3236
DELISTED
ContextLogic
LOGC
– –
-1,423
Closed -$8.1K
OKUR
3237
OnKure Therapeutics
OKUR
$162M
– –
-80
Closed -$1.33K
MAGN
3238
Magnera Corp
MAGN
$443M
– –
-289
Closed -$7.51K
LUCK
3239
Lucky Strike Entertainment
LUCK
$896M
– –
-2,312
Closed -$31.7K
CTEV
3240
Claritev Corp
CTEV
$587M
– –
-941
Closed -$30.5K
KLRS
3241
Kalaris Therapeutics
KLRS
$95.6M
– –
-105
Closed -$1.82K
WHWK
3242
Whitehawk Therapeutics
WHWK
$259M
– –
-1,086
Closed -$2.54K
TVRD
3243
Tvardi Therapeutics
TVRD
$22.5M
– –
-92
Closed -$3.01K
EVBN
3244
DELISTED
Evans Bancorp Inc
EVBN
– –
-433
Closed -$12.9K
OCEA
3245
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
– –
-717
Closed -$2.71K
ITCI
3246
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-9,484
Closed -$656K
VOXX
3247
DELISTED
VOXX International Corporation Class A
VOXX
– –
-1,148
Closed -$9.37K
IVAC
3248
DELISTED
Intevac Inc
IVAC
– –
-2,108
Closed -$8.1K
CUTR
3249
DELISTED
Cutera, Inc.
CUTR
– –
-1,245
Closed -$1.83K
OMGA
3250
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
– –
-2,013
Closed -$7.35K
128 129
130
131 132

Similar funds

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.29B AUM 2.24% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
SYBT
Stock Yards Bank & Trust Louisville, Kentucky $3.21B AUM 22.76% 1-Year Est. Return
SM
SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.